Randomised phase III trial of radical chemo/radiotherapy vs radiotherapy alone in the definitive management of localised muscle invasive TCC of the urinary bladder
Primary Sponsor
Urological Society of Australasia
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
67
Trial Chairperson
Dr Kumar Gogna, QRI Mater Centre, QLD
Trial Contact
Kumar Gogna
Clinical Trial Registration
Related Post
23 October, 2025
TROG collaboration sees international skin cancer trial open in Australia
LATEST NEWS: 23 October 2025 TROG Cancer Research has
21 October, 2025
Grandad’s mission to walk 10,000 steps a day to support cancer research
LATEST NEWS: 21 October 2025 Walking at least 10,000